3Spine, Inc., a U.S. medical device company developing total joint replacement for the lumbar spine, has raised $33 million in an oversubscribed Series C private offering. Proceeds from the financing will be used for a Phase 2 clinical study of the BalancedBack Total Joint Replacement in the United States. To date the company has raised a total of $50.3 million from private investors.

3Spine is a new kind of healthcare company founded to vertically integrate the development, clinical research, and delivery of low back total joint replacement. 3Spine is headquartered in Chattanooga, TN with research and development facilities in the Greater Boston area and clinical operations in the Cayman Islands. The result of two decades of research and exhaustive design efforts, 3Spine's MOTUS is an intuitive and revolutionary motion-enabling solution for the lumbar spine. The technology restores natural balance and maintains range of motion across a broad range of indications. www.3spine.com

3Spine, Inc. Raises $33M In Private Series C Round

3Spine, Inc. Raises $33M In Private Series C Round

Company Info